Agilent Technologies to Split in Two; Diagnostics Biz Retains Agilent Name
Agilent Technologies Inc. on Sept. 19 announced plans to separate into two publicly traded companies: one in life sciences, diagnostics and applied markets (LDA) that will retain the Agilent name, and another — to be named later — that will be comprised of Agilent's current portfolio of electronic measurement (EM) products. The separation is expected to occur through a tax-free, pro rata spinoff of the EM company to Agilent shareholders.
"Agilent has evolved into two distinct investment and business opportunities, and we are creating two separate and strategically focused enterprises to allow each to maximize its growth and success," said William (Bill) Sullivan, Agilent president and CEO.